Question 1

What happens to the lower esophageal sphincter in achalasia?

Accepted Answer

In achalasia, the lower esophageal sphincter fails to relax properly during swallowing due to degeneration of inhibitory neurons in the myenteric plexus. These neurons normally produce nitric oxide and vasoactive intestinal peptide, which are essential for sphincter relaxation. Without these neurotransmitters, the LES remains persistently contracted, creating a functional obstruction that prevents food from entering the stomach.

Question 2

How does loss of inhibitory neurons contribute to achalasia?

Accepted Answer

Achalasia results from selective depletion of inhibitory ganglion cells in the myenteric plexus that produce vasoactive intestinal peptide and nitric oxide. This degeneration is thought to be triggered by immune-mediated inflammation, possibly following viral infections like herpes simplex virus type 1 or human papillomavirus. Without these inhibitory signals, the lower esophageal sphincter cannot relax, and esophageal peristalsis becomes absent or severely impaired.

Question 3

What are the main clinical manifestations of esophageal achalasia?

Accepted Answer

Patients with achalasia typically experience progressive dysphagia, regurgitation, chest discomfort, and significant weight loss. The dilated esophagus can lead to aspiration, increasing the risk of respiratory infections and aspiration pneumonia. Chronic irritation may cause ulceration, and disease progression can result in serious clinical manifestations and complications like esophageal rupture.

Question 4

Why does food retention in achalasia increase cancer risk?

Accepted Answer

Chronic food stasis in the dilated esophagus promotes mucosal inflammation and bacterial overgrowth. The esophagus can become a capacious reservoir holding up to one liter of retained food and secretions, creating an environment for microbial colonization. This chronic irritation and inflammation significantly increase the risk of esophageal carcinoma over time.

Question 5

How does achalasia differ from other esophageal obstructions?

Accepted Answer

Achalasia is a functional obstruction without a physical blockage, caused by impaired neural control of esophageal motility. Unlike mechanical obstructions, achalasia involves loss of coordinated peristalsis and LES relaxation due to myenteric plexus degeneration. This neurogenic disorder creates a functional barrier that prevents normal food passage despite the absence of a structural lesion.

Question 6

What is the relationship between Chagas disease and achalasia?

Accepted Answer

Chagas disease, caused by Trypanosoma cruzi, has a similar pathogenesis to idiopathic achalasia, causing damage to esophageal neural plexuses. Both conditions result in degeneration of the myenteric plexus and loss of inhibitory neurons, leading to impaired LES relaxation and dysphagia. This similarity suggests that achalasia may involve immune-mediated mechanisms comparable to those in Chagas disease.

Question 7

What complications can result from prolonged esophageal dilation in achalasia?

Accepted Answer

Prolonged esophageal dilation creates a reservoir for retained food and secretions, promoting microbial colonization and chronic inflammation. This can lead to ulceration, aspiration pneumonia from regurgitated material, and increased esophageal cancer risk. In severe cases, the accumulated pressure and chronic irritation may result in esophageal rupture, a life-threatening complication.

Ахалазия пищевода